Results 141 to 150 of about 75,257 (296)
ANATOMICAL AND CLINICAL ASPECTS OF URINARY INCONTINENCE AFTER RADICAL PROSTATECTOMY
The prostate cancer is one of the most frequent causes of death among adult men. The treatment goal to eradicate the disease is obtained by the RP.
Lukyanova, Anna
core
The ‘Prostate Cancer Screening for People at Genetic Risk of Aggressive Disease’ (PATROL) study
Background Inherited (germline) pathogenic and likely pathogenic variants (gPVs) in key genes associated with increased risk of prostate cancer (PCa) now warrant more attentive PCa screening per National Comprehensive Cancer Network (NCCN) guidelines—e.g., BRCA2, HOXB13, ATM, BRCA1, MSH2, MSH6, CHEK2 and TP53.
Heather H. Cheng +12 more
wiley +1 more source
Male post-prostatectomy incontinence MDT
The management of post-prostatectomy incontinence remains controversial with ongoing confusion as to who benefits from male sling or artificial urinary sphincter.
Jeremy Ockrim +4 more
core +1 more source
In patients with mCSPC treated with apalutamide plus ADT, baseline ctDNA predicted earlier progression to CRPC and worse overall survival. Exploratory genome‐wide analysis identified 12 SNPs associated with apalutamide‐related skin rash. ABSTRACT Despite promising evidence of the efficacy of the androgen deprivation therapy (ADT) plus apalutamide in ...
Masaki Shiota +8 more
wiley +1 more source
Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males
Wei-Chang Lee,1,* Yu-Hsiang Lin,1,* Chen-Pang Hou,1 Phei-Lang Chang,1 Chien-Lun Chen,1 Horng-Heng Juang,2 Ke-Hung Tsui1 1Department of Urology, Chang Gung Memorial Hospital-Linko and Chang Gung University, College of Medicine, Taiwan, 2Department of ...
Chen CL +6 more
core
ABSTRACT Rare bleeding disorders (RBDs) represent a diverse group of inherited conditions involving coagulation factors or platelets. These conditions, such as Glanzmann thrombasthenia (GT) or severe coagulation factor deficiencies, are uncommon. In contrast, bleeding disorder of unknown cause (BDUC) is a diagnosis of exclusion without an identifiable ...
Alessandro Casini +4 more
wiley +1 more source
FOXA1 is a highly sensitive diagnostic marker for prostate cancer. Besides prostatic adenocarcinoma, it is also expressed in 57%–80% of metastatic or primary prostatic small cell carcinomas, which lose traditional prostatic markers including NKX3.1. Although it is less specific than NKX3.1, it can serve as a valuable adjunct for confirming prostatic ...
Jianping Zhao +11 more
wiley +1 more source
The effect of time from biopsy to radical prostatectomy on adverse pathologic outcomes
Premal Patel,1 Ryan Sun,1 Benjamin Shiff,1 Kiril Trpkov,2 Geoffrey Thomas Gotto3 1Section of Urology, University of Manitoba, Winnipeg, MB, Canada; 2Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB, Canada; 3Department ...
Patel P +4 more
core

